On today’s call, Ambiq Micro, Inc.’s CEO, Fumihide Esaka, will provide an overview of the company’s performance and strategy.
Q4 2025 Earnings Call March 5, 2026 8:30 AM ESTCompany ParticipantsCharlene Wan - Vice President of Corporate Marketing ...
We believe that the ongoing American experience with COVID vaccination has left an extraordinarily high medical and economic value opportunity to advance standard of care via monoclonal antibody ...
Also in attendance is Sight Sciences, Inc. Chief Operating Officer, Alison Bauerlein. Earlier today, Sight Sciences, Inc. released its financial results for the fourth quarter ended December 31, 2025, ...
Q4 2025 Earnings Call March 4, 2026 5:00 PM ESTCompany ParticipantsNick Lynton - Chief Legal & Privacy Officer and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results